ST LOUIS – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, was recently included in a list of the 20 Most Promising Cloud Solutions Providers by CIOReview Magazine.
“We are pleased that PierianDx is among those companies highlighted in the recent issue of CIOReview," said Ted Briscoe, PierianDx CEO. “This selection is further validation that our cloud-based platform is leading the way to enable personalized medicine for clinical labs.”
PierianDx provides a “one-space” solution that enables clinical labs to streamline their workflow and access a single cloud workspace by providing a curated knowledgebase, comprehensive analysis, insightful interpretations, and precise reporting. Leading health systems, academic medical centers, cancer centers, children’s hospitals and commercial labs worldwide are utilizing PierianDx’s Clinical Genomicist Workspace (CGW).
“The adoption of Next Generation Sequencing (NGS) testing has led to advances in patient treatment and the rise of more precise diagnoses and treatment techniques,” said Briscoe. “However, the increased use of NGS tests involves major challenges pertaining to managing scalability and handling the complexities of larger gene sets. CGW addresses these challenges, enabling clinical labs to make personalized medicine a reality.”
Since licensing the technology assets from Washington University Medical Center in 2014, PierianDx has expanded the CGW platform to include exome and whole genome support, increased its customer base and secured $9.25 million in Series A financing.
For more information about PierianDx in CIOReview, click the links below:
PierianDx enables health systems, academic medical centers and commercial labs to deliver patient-specific diagnosis and treatments based on an individual’s DNA. In use since 2011, and regularly enhanced with new patient, clinical and research data, PierianDx’s proprietary Clinical Genomicist Workspace (CGW) provides clinical labs more streamlined and accurate analysis, interpretation, and reporting needed to accelerate their personalized medicine programs. PierianDx also recently launched the NGS Gateway Program, a CAP-accredited, CLIA-certified lab that complements PierianDx partners’ in-house NGS testing services. Clinical Genomicist Workspace™ is a trademark of PierianDx, Inc.
Published from Fremont, California, CIOReview is a print magazine that explores and understands the plethora of ways adopted by firms to execute the smooth functioning of their businesses. A distinguished panel comprising of CEOs, CIOs, IT VPs including CIOReview editorial board finalized the “20 Most Promising Cloud Solution Providers 2016” in the U.S. and shortlisted the best vendors and consultants. For more info: http://www.cioreview.com/